Edit Symbol List

Symbol List Views

• FlashQuotes
• InfoQuotes

Stock Details

• Real-Time Quotes
• Summary Quotes
• After Hour Quotes
• Pre-market Quotes
• Historical Quotes
• Options Chain

CHARTS

• Basic Charts
• Interactive Charts
• After Hour Charts
• Pre-market Charts

COMPANY NEWS

• Company Headlines
• Press Releases
• TheStreet.com
• Fool.com

STOCK ANALYSIS

• Analyst Research
• Guru Analysis
• Stock Report
• View Competitors
• Stock Consultant
• Stock Comparison

FUNDAMENTALS

• Annual Report
• Financials
• Revenue/EPS
• Real-Time SEC
• Short Interest

HOLDINGS

• Holdings Summary
  (Ownership)
• Detailed Institutional
  Holdings
• Insider Form 4

SUPG: Stock Quote & Summary Data

$ 2.72 0.02 0.74%
Nov. 20, 2009 Market Closed
Update Quotes: . Updates every 7 Seconds.

SUPG | SuperGen, Inc. | Common Stock | Market : NASDAQ-GM

News

Price Charts

Company Financials

Hoovers Profile

Last Sale	$ 2.72
Change Net / %	0.02 0.74%
Best Bid / Ask	N/A / N/A
1y Target Est:	$ 3.00
Today's High / Low	$ 2.75 /  $ 2.69
Share Volume	141,300
50 Day Avg. Daily Volume	259,577
Previous Close	$ 2.70
52 Wk High / Low	$ 3.30 / $ 1.54
Shares Outstanding	59,151,000
Market Value	$ 160,890,720
P/E Ratio	30.22
Forward P/E (1yr)	NE
Earnings Per Share	$ 0.09
Annualized Dividend	N/A
Ex Dividend Date	N/A
Dividend Payment Date	N/A
Current Yield	N/A
Beta	1.32
NASDAQ Official Open Price:	$ 2.69
Date of NASDAQ Official Open Price:	Nov. 20, 2009
NASDAQ Official Close Price:	$ 2.72
Date of NASDAQ Official Close Price:	Nov. 20, 2009

Intraday Chart

5d | 1m | 6m | 12m | More Charting

 Company Description (as filed with the SEC)

We incorporated in March 1991 as a California corporation and changed our state of incorporation to Delaware in May 1997. Our executive offices are located at 4140 Dublin Blvd., Suite 200, Dublin, CA, 94568 and our telephone number at that address is (925) 560-0100. We maintain a website on the internet at www.supergen.com. This is a textual reference only. We do not incorporate the information on our website into this annual report on Form 10-K, and you should not consider any information on, or that can be accessed through, our website as part of this annual report on Form 10-K. Overview We are a pharmaceutical company dedicated primarily to the discovery, development and commercialization of therapies to treat patients with cancer. Historically we acquired products that were developed by other companies and applied additional developmental effort to expand sales or advance these products clinically towards potential approval for marketing.  ... More ...